4.7 Article

shRNA-mediated knockdown of KNTC1 inhibits non-small-cell lung cancer through regulating PSMB8

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer treatment and survivorship statistics, 2019

Kimberly D. Miller et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Review Multidisciplinary Sciences

The biology and management of non-small cell lung cancer

Roy S. Herbst et al.

NATURE (2018)

Article Oncology

Cancer Statistics, 2017

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2017)

Article Oncology

Cancer treatment and survivorship statistics, 2016

Kimberly D. Miller et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2016)

Article Multidisciplinary Sciences

Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome

Satyendra C. Tripathi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Oncology

Non-small cell lung cancer: current treatment and future advances

Cecilia Zappa et al.

TRANSLATIONAL LUNG CANCER RESEARCH (2016)

Article Oncology

Inhibition of Hec1 as a novel approach for treatment of primary liver cancer

Lynn Y. L. Huang et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)

Article Gastroenterology & Hepatology

Hec1/Ndc80 is overexpressed in human gastric cancer and regulates cell growth

Ying Qu et al.

JOURNAL OF GASTROENTEROLOGY (2014)

Review Cell Biology

Molecular mechanisms of proteasome assembly

Shigeo Murata et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)

Review Oncology

Aurora-kinase inhibitors as anticancer agents

N Keen et al.

NATURE REVIEWS CANCER (2004)

Review Biochemistry & Molecular Biology

Centromeres and kinetochores: From epigenetics to mitotic checkpoint signaling

DW Cleveland et al.

Article Cell Biology

Human Zw10 and ROD ave mitotic checkpoint proteins that bind to kinetochores

GKT Chan et al.

NATURE CELL BIOLOGY (2000)